REperfusion Facilitated by LOcal Adjunctive Therapy in ST-elevation Myocardial Infarction
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 247 participants.
Also called NCT01747174
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 247 participants
- Sponsor
- University Hospitals, Leicester
- Registry
-
NCT01747174 -
2010-023211-34
-
- Other papers using this trial's data
- Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01747174. Randomized; single masking; primary purpose prevention. Start 2011-10 (registry gives no type); primary completion 2014-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- REperfusion Facilitated by LOcal Adjunctive Therapy in ST-elevation Myocardial Infarction
- Acronym
- REFLO-STEMI
- Condition
- ST-elevation Myocardial Infarction (STEMI)
- Intervention (Drug)
- IC Adenosine
- Intervention (Drug)
- IC Sodium nitroprusside (SNP)
- Intervention (Procedure)
- Standard PCI (percutaneous coronary intervention)
- Lead sponsor
- University Hospitals, Leicester
Record details
- Record id
cardio:ct-nct01747174- Content hash
a1420170c9d776b29e7583b90d0b3189159bac7f7e93373bd93f45352d61465b